May 5, 2016 - Disparities in the gut microbiome between healthy people and women with estrogen-driven breast cancer may indicate possible biomarkers based on the microbiome that could help to mitigate the risk of certain cancers.
The estrobolome is the gut bacterial genes that are capable of metabolizing estrogens in gut bacteria. Residential microbes, whose population includes bacteria, viruses, Archaea, and Eukaryotes, are increasingly recognized for playing important roles in health and disease. Read more here.
No comments:
Post a Comment